BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28296507)

  • 1. LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells.
    Shen CJ; Cheng YM; Wang CL
    J Drug Target; 2017 Aug; 25(7):637-644. PubMed ID: 28296507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b.
    Zhang S; Zhang G; Liu J
    APMIS; 2016 Aug; 124(8):649-58. PubMed ID: 27272214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-Myc-activated long non-coding RNA PVT1 enhances the proliferation of cervical cancer cells by sponging miR-486-3p.
    Wang C; Zou H; Chen A; Yang H; Yu X; Yu X; Wang Y
    J Biochem; 2020 Jun; 167(6):565-575. PubMed ID: 31943014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA PVT1 promotes proliferation and invasion through enhancing Smad3 expression by sponging miR-140-5p in cervical cancer.
    Chang QQ; Chen CY; Chen Z; Chang S
    Radiol Oncol; 2019 Oct; 53(4):443-452. PubMed ID: 31626590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non‑coding RNA plasmacytoma variant translocation 1 gene promotes the development of cervical cancer via the NF‑κB pathway.
    Wang C; Zou H; Yang H; Wang L; Chu H; Jiao J; Wang Y; Chen A
    Mol Med Rep; 2019 Sep; 20(3):2433-2440. PubMed ID: 31322217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA PVT1 Facilitates Cervical Cancer Progression via Negative Regulating of miR-424.
    Gao YL; Zhao ZS; Zhang MY; Han LJ; Dong YJ; Xu B
    Oncol Res; 2017 Sep; 25(8):1391-1398. PubMed ID: 28276314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152.
    Zheng J; Yu F; Dong P; Wu L; Zhang Y; Hu Y; Zheng L
    Oncotarget; 2016 Sep; 7(39):62886-62897. PubMed ID: 27588491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.
    Iden M; Fye S; Li K; Chowdhury T; Ramchandran R; Rader JS
    PLoS One; 2016; 11(5):e0156274. PubMed ID: 27232880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA-PVT1 Facilitates Invasion Through Upregulation of MMP9 in Nonsmall Cell Lung Cancer Cell.
    Chen W; Zhu H; Yin L; Wang T; Wu J; Xu J; Tao H; Liu J; He X
    DNA Cell Biol; 2017 Sep; 36(9):787-793. PubMed ID: 28731781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer.
    Chang Z; Cui J; Song Y
    Gene; 2018 May; 654():36-42. PubMed ID: 29452232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial-mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract.
    Lu L; Luo F; Liu Y; Liu X; Shi L; Lu X; Liu Q
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):276-85. PubMed ID: 26415832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA Plasmacytoma Variant Translocation 1 (PVT1) Promotes Colon Cancer Progression via Endogenous Sponging miR-26b.
    Zhang R; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Liu Y
    Med Sci Monit; 2018 Dec; 24():8685-8692. PubMed ID: 30504754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.
    Xiong Y; Sun F; Dong P; Watari H; Yue J; Yu MF; Lan CY; Wang Y; Ma ZB
    J Exp Clin Cancer Res; 2017 Apr; 36(1):48. PubMed ID: 28399926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a.
    Liu HT; Fang L; Cheng YX; Sun Q
    Cancer Med; 2016 Dec; 5(12):3512-3519. PubMed ID: 27794184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells.
    Song J; Li Y
    Cancer Sci; 2017 Jan; 108(1):23-31. PubMed ID: 27743413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer.
    Huang T; Liu HW; Chen JQ; Wang SH; Hao LQ; Liu M; Wang B
    Biomed Pharmacother; 2017 Apr; 88():302-308. PubMed ID: 28122299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA PVT1-5 promotes cell proliferation by regulating miR-126/SLC7A5 axis in lung cancer.
    Li H; Chen S; Liu J; Guo X; Xiang X; Dong T; Ran P; Li Q; Zhu B; Zhang X; Wang D; Xiao C; Zheng S
    Biochem Biophys Res Commun; 2018 Jan; 495(3):2350-2355. PubMed ID: 29277611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53.
    Lu J; Xu F; Lu H
    Life Sci; 2020 Nov; 260():118305. PubMed ID: 32827544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lentinan Attenuated the PM2.5 Exposure-Induced Inflammatory Response, Epithelial-Mesenchymal Transition and Migration by Inhibiting the PVT1/miR-199a-5p/caveolin1 Pathway in Lung Cancer.
    Qi H; Liu Y; Wang N; Xiao C
    DNA Cell Biol; 2021 May; 40(5):683-693. PubMed ID: 33902331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.